Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy The following represents disclosure information provided by authors of this manuscript. All ...
Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...
GSM describes the physical findings and symptoms that are due to decreased estrogen secretion. Estrogen is the most effective therapy for moderate/severe conditions because it rapidly restores ...
With the emergence of antibody-drug conjugates, the genitourinary cancers space is rapidly evolving. Dr Ferris addresses ...
Cabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study. Genitourinary cancers — particularly urothelial cancer – saw activity with the ...
Seattle Cancer Care Alliance (SCCA), UW Medicine, and Fred Hutch physicians and researchers who are leaders in treating genitourinary cancers will attend and present their research at the ...
Donna Hansel, MD, PhD, of University of California, San Diego, School of Medicine, explains her use of human bladder cancer cells in her research. Having numerous therapies to treat prostate cancer ...
Austin, May 08, 2025 (GLOBE NEWSWIRE) -- Genitourinary Drugs Market Size & Trends: The global Genitourinary Drugs Market size to reach USD 33.37 billion by 2032, up from USD 29.69 billion in 2024, ...
Racial disparities in stage IV prostate cancer outcomes in the Veterans Affairs hospital system. Cardiovascular events and clinical responses in prostate cancer patients treated with transcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results